• LY2109761: TGF-β Receptor Type I and II Dual Inhibitor in Tr

  2026-07-28

  LY2109761 empowers researchers to dissect and modulate the TGF-β signaling pathway with nanomolar precision, enabling robust anti-tumor and anti-fibrotic applications. This article delivers actionable workflows, troubleshooting strategies, and comparative insights for integrating this selective TβRI/II kinase inhibitor into cutting-edge oncology and fibrosis research.

• Endogenous H2S Deficiency and ER Stress in Diabetic Cardiomy

  2026-07-28

  This study identifies a mechanistic link between diminished endogenous hydrogen sulfide (H2S) production and endoplasmic reticulum (ER) stress in the pathogenesis of diabetic cardiomyopathy (DCM). The findings reveal that restoring H2S levels can mitigate ER stress and lipotoxic myocardial injury, offering a new perspective for experimental modeling and therapeutic exploration.

• Scenario-Driven Best Practices with Protein A/G Magnetic Bea

  2026-07-27

  This article delivers practical, scenario-based guidance for biomedical researchers and laboratory professionals leveraging Protein A/G Magnetic Beads (SKU K1305) in immunoprecipitation, co-IP, and chromatin immunoprecipitation workflows. It addresses real-world experimental challenges—such as assay reproducibility, background reduction, and vendor reliability—while highlighting the performance and specificity advantages of these recombinant Protein A and Protein G beads.

• Applied Workflows with Recombinant Human FGF-19 Protein

  2026-07-27

  Recombinant Human FGF-19 (E.coli, Tag Free, Lyophilized) enables researchers to unlock highly reproducible metabolic and signaling assays with unmatched purity and validated bioactivity. This article delivers actionable workflows, troubleshooting insights, and cross-study comparisons to maximize assay success in FGF-19/FGFR4 pathway research.

• LY2109761: Applied Strategies for TGF-β Receptor Dual Inhibi

  2026-07-26

  LY2109761, a dual TGF-β receptor type I and II inhibitor, offers researchers a robust tool to dissect Smad2/3 signaling and modulate tumor and fibrosis pathways. This guide translates recent evidence and advanced workflows into actionable protocols, troubleshooting, and enhancements for translational oncology and fibrosis studies.

• Sumatriptan’s Anti-Inflammatory Actions: Systematic Review I

  2026-07-25

  Ala et al.'s systematic review reveals that sumatriptan, beyond its established role as a migraine therapy, exerts significant anti-inflammatory effects through modulation of cytokines, nitric oxide signaling, and peptide release. These findings suggest potential new directions for the use of sumatriptan in inflammation-driven disease models.

• Itraconazole (SKU B2104): Reliable Antifungal for Candida As

  2026-07-24

  This article addresses practical laboratory challenges in antifungal research by showcasing how Itraconazole (SKU B2104) offers reproducible, data-driven solutions for cell viability, proliferation, and cytotoxicity assays. Drawing on peer-reviewed evidence and validated protocols, it guides researchers through common pitfalls and demonstrates why APExBIO’s Itraconazole is a trusted reagent for contemporary Candida studies.

• DiscoveryProbe FDA-approved Drug Library: Mechanisms and Ben

  2026-07-24

  The DiscoveryProbe FDA-approved Drug Library enables standardized, high-throughput screening of 2,320 clinically validated bioactive compounds. Its stability, regulatory breadth, and protocol flexibility make it a robust tool for drug repositioning screening and pharmacological target identification.

• Ganetespib (STA-9090): Mechanistic Insights and Assay Innova

  2026-07-23

  Discover how Ganetespib (STA-9090), a potent Hsp90 inhibitor, is transforming cancer research through advanced mechanism-of-action studies and practical assay design. This article delivers unique, evidence-based guidance for leveraging Ganetespib’s capabilities beyond common protocols.

• Dynamically Covalent LNPs Enable CRISPR-Cas9 Editing in CNV

  2026-07-23

  Cao et al. introduce dynamically covalent lipid nanoparticles (LNPs) for efficient, nonviral delivery of Cas9 mRNA and sgRNA, enabling precise genome editing to treat choroidal neovascularization in mice. Their platform demonstrates high mRNA transfection efficiency, reduced immunogenicity, and a robust reduction in pathological vascularization, establishing a new direction for ocular gene therapy.

• G418 Sulfate (Geneticin): Optimized Selection and Antiviral

  2026-07-22

  G418 Sulfate (Geneticin) is a dual-purpose powerhouse, enabling both high-fidelity genetic selection and targeted antiviral research. This article delivers actionable workflows, troubleshooting insights, and a translational perspective rooted in the latest mechanistic discoveries.

• Annexin V-FITC/7-AAD Apoptosis Kit: Precision in Cell Death

  2026-07-22

  The Annexin V-FITC/7-AAD Apoptosis Kit from APExBIO streamlines early apoptosis and necrosis detection with rapid, quantitative workflows ideal for translational cancer research. Its dual-parameter design enables high-resolution discrimination of cell death stages, as demonstrated in recent osteosarcoma therapeutic studies.

• Vascularized Pancreatic Progenitors from hPSCs via WNT Modul

  2026-07-21

  Sang et al. introduce a protocol enabling co-differentiation of mesoderm and endoderm from human pluripotent stem cells (hPSCs), yielding vascularized pancreatic progenitors (vPPs). This approach leverages precise WNT signaling modulation with CHIR-99021 and holds promise for regenerative diabetes therapies.

• Caspase-3 Colorimetric Assay Kit: Practical Apoptosis Detect

  2026-07-21

  The Caspase-3 Colorimetric Assay Kit (SKU: K2008) provides researchers with a reliable, rapid method to quantify DEVD-dependent caspase-3 activity in apoptosis studies. This product is best suited for biochemical workflows requiring accurate measurement of a cysteine-dependent aspartate-directed protease, especially in neurodegenerative disease and caspase signaling pathway research. It should not be used for in vivo imaging or mechanistic studies beyond its validated substrate specificity.

• WIP1 Phosphatase Attenuates Pyroptosis in Septic AKI via p38

  2026-07-20

  This study reveals that WIP1 phosphatase suppresses p38 MAPK-driven pyroptosis in sepsis-associated acute kidney injury (AKI), providing new mechanistic insight into renal inflammation control. These findings position WIP1 as a potential molecular target for limiting inflammatory damage in septic AKI.

417 records 1/28 page Next 12345 下5页 Last page